Events
FT Global Pharma & Biotechnology Conference 2019
Addressing disruption and transformation in pharma
11–12 Nov 2019 | Royal Lancaster, London
This industry-leading event brings together executives from the world’s largest pharmaceutical and biotechnology companies, their health care counterparts, and other key stakeholders across the life sciences value chain to deliberate on key trends and issues that are set to reshape the life sciences sector.
Disruption will continue to take center stage in the life sciences economy for the rest of 2019 and beyond. The sector is constantly evolving all while addressing some significant issues—pricing pressures in many parts of the world, growth in a number of markets, competition from new entrants in the prevention and wellness space, and rise of pricey, potentially curative gene and cell therapies—creating a vacuum for transformation, while generating opportunities and challenges for stakeholders in their journey of care delivery. Executives from across the industry are set to come together at the 37th edition of the FT Global Pharmaceutical and Biotechnology Conference to discuss these trends and more and discuss how to create a successful economic model for life sciences ecosystem of the future.
Visit the FT’s conference page for more information on speakers.
25 percent registration discount
(Use code Deloitte25 when registering)
To register for the conference and learn about the speakers, agenda, and topics, visit:
https://live.ft.com/Events/2019/FT-Global-Pharmaceutical-and-Biotechnology-Conference
Key issues to be addressed at the conference:
- Transformation and talent strategies
- Chief digital officer forum
- Pharma’s pricing conundrum
- Alternative funding models for R&D
- Intellectual property
- Rewarding innovation and the regulation we need
- Digital R&D
- The global competition for investment
- Innovation on the frontiers or science, medicine and technology
- What pharma needs to do better at telling its story
Deloitte sessions
11 November 2019 | 1:35 p.m.
Panelists:
- Camilla Sylvest, EVP, Commercial Strategy and Corporate Affairs, Novo Nordisk
- Lord Drayson, PhD, CEO, Sensyne Health
- Eddie Martucci, Co-Founder and CEO, Akili Interactive
- Hanno Ronte, Partner, Deloitte
- Dan Vahdat, Founder, Medopad
11 November 2019 | 3:15 p.m.
Panelists: -
Session keynote:
- Marie-France Tschudin, President, Pharmaceuticals, Novartis
- Mark Howells, VP Talent and Development, AstraZeneca
- Bahija Jallal, CEO, Immunocore
Moderator:
- Greg Reh, Global Life Sciences & Health Care Industry Leader, Deloitte
12 November 2019 | 9:20 a.m.
Panelists:
- Mark Trusheim, Strategic Director, NEWDIGS, MIT Centre for Biomedical Innovation
- Yvonne Greenstreet, Chief Operating Officer, Alnylam
- Justin McCarthy, Senior Vice President, Patient and Health Impact Group, Pfizer
- Michael Oberreiter, Head of Global Access, Roche
Moderator:
- Greg Reh, Global Life Sciences & Health Care Industry Leader, Deloitte
12 November 2019 | 12:10 p.m.
Panelists:
- Virginia Acha, Global Regulatory Policy for Europe, Middle East, Africa and Asia, MSD
Moderator:
- Greg Reh, Global Life Sciences & Health Care Industry Leader, Deloitte
12 November 2019 | 9:05 a.m.
Keynote Address:
Joaquin Duato, Vice Chairmam of the Executive Committee, Johnson & Johnson
Moderator:
Greg Reh, Global Life Sciences & Health Care Industry Leader, Deloitte
Eminence
Explore our most recent insights:
Tackling digital transformation
Digital transformation in life sciences
Optimizing market access
2019 Global life sciences outlook
Gain the edge in a fast-moving market
Embracing the future of work to unlock R&D productivity
Return on capital performance in life sciences and health care
A bold future for life sciences regulation: Predictions 2025
The next wave of innovation
Digital R&D
Contacts
Recommendations
Medtech and the Internet of Medical Things
How connected medical devices are transforming health care
2019 Global life sciences outlook
Focus and transform| Accelerating change in life sciences